1. Identification of two potential glycogen synthase kinase 3β inhibitors for the treatment of osteosarcoma
   Kaimin Lu et al, 2018 CrossRef
2. Berberine coated mannosylated liposomes curtail RANKL stimulated osteoclastogenesis through the modulation of GSK3β pathway via upregulating miR-23a
   Sali Sujitha et al, 2019, International Immunopharmacology CrossRef
3. A case of minimal change disease after the administration of anti receptor activator of nuclear factor kappa B ligand (RANKL) monoclonal antibody: a case report
   Keisuke Horikoshi et al, 2020, BMC Nephrol CrossRef